Zantac Heartburn Medication
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication Zantac exposes users to unsafe levels of the carcinogen N-Nitrosodimethylamine (NDMA). (Dimesky et al v. Sanofi-Aventis U.S., LLC, Sanofi US Services Inc., Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-1517, D. CT.)
Class-Action Tracker
The Latest
When Food Delivery Comes with a Side of Junk Fees
TINA.org urges the FTC to adopt a fee disclosure rule for the online food delivery market.
TINA.org Supports FTC’s Settlement with TruHeight
Comment pushes for strong oversight of supplement companies targeting kids.
Legacy Cremation Services Violating Federal Court Order
TINA.org complaint with FTC and DOJ urges renewed action to stop serial offender.
Legacy Cremation Services Brazenly Violating Federal Court Order
MADISON, CONN. May 12, 2026 – Legacy Cremation Services continues to prey on grieving families nationwide despite a federal court order intended to stop its deceptive practices, according to a…
Garden & Gather’s ‘100% Money Back Guarantee’ and ‘Free Returns’
Consumers’ attempts to obtain a full refund may only yield a meager harvest.